Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults

Journal of Investigative Medicine

Volumn 52, Issue 3, 2004, Pages 192-201

  Bray, Christopher L ^a   Cahill, Kevin S ^a   Oshier, Joseph T ^a   Peden, Carmen S ^a   Theriaque, Douglas W ^a   Flotte, Terence R ^a   Stacpoole, Peter W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Central nervous system stimulants pharmacology; Cognitive testing drug effects; Heart rate drug effects; Human; Methylphenidate pharmacology; Sleep deprivation; Stimulant abuse; Student

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SLEEP DEPRIVATION;

EID: 3042849061     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-52-03-34     Document Type: Article

References (49)

1. Woodworth T. DEA Congressional testimony. Committee on Education and the Workforce. Washington, DC: US Department of Justice; 2000.
2. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000;49:143-5.
3. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 2000;14:53-60.
4. Volkow ND, Wang GJ, Fowler JS, et al. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 1999;291:409-15.
5. Volkow ND, Ding YS, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995;52:456-63.
6. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001;21:RC121.
7. Hyde H. Committee on the Judiciary [press release] 2000 Sept 14. Available at: http://www.house.gov/judiciary/na091400.htm (accessed March 2, 2004).
8. Thomas K. Stealing, dealing, and Ritalin. USA Today 2000 Nov 27;1D-2D.
9. Sensenbrenner FJ, Hyde H. Attention disorder drugs - few incidents of diversion or abuse identified by schools. Washington, DC: US General Accounting Office; 2001.
10. Drug Enforcement Agency. Methylphenidate. Washington, DC: US Department of Justice; 1995.
11. Musser CJ, Ahmann PA, Theye FW, et al. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J Dev Behav Pediatr 1998;19:187-92.
12. Massello W 3rd, Carpenter DA. A fatality due to the intranasal abuse of methylphenidate (Ritalin). J Forensic Sci 1999;44:220-1.
13. Klorman R, Bauer LO, Coons HW, et al. Enhancing effects of methylphenidate on normal young adults' cognitive processes. Psychopharmacol Bull 1984;20:3-9.
14. Camp-Bruno JA, Herting RL. Cognitive effects of milacemide and methylphenidate in healthy young adults. Psychopharmacology (Berl) 1994;115:46-52.
15. Brumaghim JT, Klorman R. Methylphenidate's effects on paired-associate learning and event-related potentials of young adults. Psychophysiology 1998;35:73-85.
16. Bishop C, Roehrs T, Rosenthal L, Roth T. Alerting effects of methylphenidate under basal and sleep-deprived conditions. Exp Clin Psychopharmacol 1997;5:344-52.
17. Orton DI, Gruzelier JH. Adverse changes in mood and cognitive performance of house officers after night duty. BMJ 1989;298:21-3.
18. Deary IJ, Tait R. Effects of sleep disruption on cognitive performance and mood in medical house officers. BMJ 1987;295:1513-6.
19. Leonard C, Fanning N, Attwood J, Buckley M. The effect of fatigue, sleep deprivation and onerous working hours on the physical and mental wellbeing of pre-registration house officers. Ir J Med Sci 1998;167:22-5.
20. Deaconson TF, O'Hair DP, Levy MF, et al. Sleep deprivation and resident performance. JAMA 1988;260:1721-7.
21. Pilcher JJ, Huffcutt AI. Effects of sleep deprivation on performance: a meta-analysis. Sleep 1996;19:318-26.
22. Drummond SP, Brown GG, Gillin JC, et al. Altered brain response to verbal learning following sleep deprivation. Nature 2000;403:655-7.
23. Stacpoole PW, Fisher WR, Flotte TR, et al. Teaching hypothesis-oriented thinking to medical students: the University of Florida's clinical investigation program. Acad Med 2001;76:287-92.
24. Rush CR, Griffiths RR. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 1996;16:146-57.
25. Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 1998;51:1532-7.
26. Fujita M, Woods SW, Verhoeff NP, et al. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. Eur J Pharmacol 1999;368:161-72.
27. Dao-Castellana MH, Samson Y, Legault F, et al. Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings. Psychol Med 1998;28:1039-48.
28. Mintzer MZ, Frey JM, Yingling JE, Griffiths RR. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behav Pharmacol 1997;8:561-74.
29. Cloyd JC, Lalonde RL, Beniak TE, Novack GD. A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia 1998;39:520-6.
30. Benedict RH, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 1998;20:339-52.
31. Giovagnoli AR, DelPesce M, Mascheroni S, et al. Trail Making Test: normative values from 287 normal adult controls. Ital J Neurol Sci 1996;17:305-9.
32. Feinstein A, Brown R, Ron M. Effects of practice of serial tests of attention in healthy subjects. J Clin Exp Neuropsychol 1994;16:436-47.
33. Dyche GM, Johnson DA. Development and evaluation of CHIPASAT, an attention test for children: II Test-retest reliability and practice effect for a normal sample. Percept Mot Skills 1991;72:563-72.
34. Cannon BJ. Interference as measured by the Stroop Color-Word Test and the Direction-Word Test with varied comparison stimuli. Percept Mot Skills 1998;86(3 Pt 1):1019-24.
35. McCann UD, Penetar DM, Shaham Y, et al. Sleep deprivation and impaired cognition. Possible role of brain catecholamines. Biol Psychiatry 1992;31:1082-97.
36. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clin Proc 2000;75:711-21.
37. Giros B, Jaber M, Jones SR, et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-12.
38. Volkow ND, Ding YS, Fowler JS, et al. A new PET ligand for the dopamine transporter: studies in the human brain. J Nucl Med 1995;36:2162-8.
39. Gelfand S, Clark LD, Herbert EW, et al. Magnesium pemoline: stimulant effects on performance of fatigued subjects. Clin Pharmacol Ther 1968;9:56-60.
40. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26:117-26.
41. Howard SK, Gaba DM, Rosekind MR, Zarcone VP. The risks and implications of excessive daytime sleepiness in resident physicians. Acad Med 2002;77:1019-25.
42. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci U S A 1996;93:10388-92.
43. Buxton N, McConachie NS. Amphetamine abuse and intracranial haemorrhage. J R Soc Med 2000;93:472-7.
44. Brauer LH, Ambre J, De Wit H. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol 1996;16:72-6.
45. Wang GJ, Volkow ND, Fowler JS, et al. Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci 1994;54:L143-6.
46. Sloan MA, Mattioni TA. Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke 1992;23:427-30.
47. Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 1990;113:821-7.
48. Derlet RW, Rice P, Horowitz BZ, Lord RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med 1989;7:157-61.
49. McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg 2000;14:449-54.